Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trillium Therapeutics (TRIL)
NASDAQ:TRIL
RESEARCH TOOLSreports
Holding TRIL?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 09, 2021 | Robert Uger Chief Scientific Officer | xxxxxxxxxxxxx | |
| May 13, 2021 | Skvarka Jan President & Ceo,director | xxxxxxxxxxxxx | |
| Feb 10, 2021 | Robert Uger Chief Scientific Officer | xxxxxxxxxxxxx | |
| Jan 13, 2021 | Robert Uger Chief Scientific Officer | xxxxxxxxxxxxx |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2021 | xxxxxxxxxxxxx | $2195000 | |
| Sep 30, 2021 | xxxxxxxxxxxxx | $2944812 | |
| Sep 30, 2021 | xxxxxxxxxxxxx | $3510437 | |
| Sep 30, 2021 | xxxxxxxxxxxxx | $5987960 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Trillium Therapeutics (TRIL)?
Currently, no data Available
What percentage of Trillium Therapeutics (TRIL) stock is held by institutional investors?
Currently, no data Available
What percentage of Trillium Therapeutics (TRIL) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Trillium Therapeutics (TRIL)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.